Advertisements


We are Sorry, This Page doesn't Exist


Valeant Pharmaceuticals Intl Inc Has New Name But Same Problems

InvestorPlace - Stock Market News, Stock Advic.....»»

Category: topSource: investorplaceJun 9th, 2018

FDA PDUFA Date for Valeant Pharmaceuticals IDP-118 is June 18, 2017

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2018

Valeant Pharmaceuticals Woes Continue as FDA Fails to Approve Plaque Psoriasis Lotion

Valeant Pharmaceuticals shares were down over 5% in premarket trading Monday after the FDA failed to approve the company's lotion intended to treat plaque psoriasis......»»

Category: blogSource: 247wallstJun 18th, 2018

Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion

Valeant Pharmaceuticals International Inc. shares dropped 5.4% in premarket trade on Mond.....»»

Category: topSource: marketwatchJun 18th, 2018

Valeant Pharmaceuticals Intl Inc Shares Sink on Psoriasis Treatment Rejection by FDA

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Valean.....»»

Category: topSource: investorplaceJun 19th, 2018

Valeant Down as FDA Refuses to Approve Duobrii For Psoriasis

Valeant (VRX) suffers a setback as the FDA issues a CRL for its plaque psoriasis lotion, Duobrii. Shares of Valeant Pharmaceuticals International, In.....»»

Category: personnelSource: nytJun 19th, 2018

Bausch Health expects Raleigh-based subsidiary to double revenue in 5 years

Bausch Health, formally known as Valeant Pharmaceuticals International, has released expectations for its Raleigh-based division in the company’s 2Q earnings report......»»

Category: topSource: bizjournalsAug 9th, 2018

Bausch Health Insiders Are Stepping Up Their Stock Buys

Three executives at the former Valeant Pharmaceuticals have bought $5.1 million in shares so far this year......»»

Category: topSource: barronsSep 22nd, 2018

Insider Weekends: 3 Insiders Of The Company Formerly Known As Valeant Pharmaceuticals Buy Stock

Insider Weekends: 3 Insiders Of The Company Formerly Known As Valeant Pharmaceuticals Buy Stock.....»»

Category: topSource: seekingalphaSep 25th, 2018

Short seller who foresaw Valeant crash now bets on Tesla falling

Short seller Fahmi Quadir, who bet against the drugmaker formerly known as Valeant Pharmaceuticals around its peak in 2015, is now betting on a dramatic drop in Tesla Inc. shares......»»

Category: topSource: moneycentralOct 9th, 2018

Short seller who foresaw Valeant crash now bets on Tesla falling

Short seller Fahmi Quadir, who bet against the drugmaker formerly known as Valeant Pharmaceuticals around its peak in 2015, is now betting on a dramatic drop in Tesla Inc. shares......»»

Category: topSource: moneycentralOct 9th, 2018

Ex-Valeant, Philidor executives get prison for fraud

A former executive at Valeant Pharmaceuticals International Inc and the former head of a start-up mail-order pharmacy were sentenced to one year in prison on Tuesday after being convicted of defrauding the drugmaker through a secret kickback scheme......»»

Category: topSource: reutersOct 30th, 2018

Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study

NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression. read more.....»»

Category: blogSource: benzingaApr 30th, 2024

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday

read more.....»»

Category: blogSource: benzingaApr 29th, 2024

Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends

Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow. Latest Ratings for INCY DateFirmActio.....»»

Category: blogSource: benzingaApr 23rd, 2024

Skyhawk’s latest biopharma collaboration is worth up to $1.8B

Skyhawk has also previously unveiled partnerships with the likes of Vertex Pharmaceuticals Inc., Bristol Myers Squibb, Takeda Pharmaceuticals, Genentech and Biogen Inc......»»

Category: topSource: bizjournalsApr 23rd, 2024

EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent

Adial Pharmaceuticals' genetic diagnostic patent, expanding treatment for alcohol and drug dependencies. CEO highlights the significance. read more.....»»

Category: blogSource: benzingaApr 22nd, 2024

Marinus Pharmaceuticals loses 80% of its market value in one day after setback for new drug candidate

Marinus Pharmaceuticals said it will implement cost-cutting measures to extend its cash runway beyond the fourth quarter of 2024......»»

Category: topSource: bizjournalsApr 15th, 2024

Breaking Down Regeneron Pharmaceuticals: 13 Analysts Share Their Views

Latest R.....»»

Category: blogSource: benzingaApr 12th, 2024

Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors" Radars Today

On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones I.....»»

Category: blogSource: benzingaApr 10th, 2024